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Abstract
Background: The implementation of new public healthcare models that stimulate the use of natural products from
traditional medicine, as a so-called integrated medicine, refers to an approach that use best of both conventional
medicine and traditional medicine. Propolis is a widely used natural product by different ancient cultures and known
to exhibit biological activities beneficial for health. The large number of studies conducted with propolis had shown
that its chemical composition differs as a function of the climate, plant diversity and bee species and plays an
important role on its therapeutic properties. The aim of this study was to analyse the phytochemical profile of the
ethanolic extract of red propolis (EEP) and its fractionation, antioxidant action of EEP and its fractions hexane,
cloroform and ethyl acetate and cytotoxic activity of EEP on human tumour cell lines SF-295 (glioblastoma),
OVCAR-8 (ovary) and HCT-116 (colon).
Methods: EEP was obtained by maceration with absolute ethanol, then it was concentrated in rotaevaporator up
to complete evaporation of the solvent. The crude extract was fractionated with hexane, ethyl acetate, chloroform and
methanol and they were subjected to phytochemical screening and total phenolic compounds. Antioxidant activity of
EEP and fractions was done by means of the 2,2-diphenyl-1-picryhydrazyl (DPPH) method. Biomarkers of red propolis
were identified by LC-Orbitrap-FTMS. To assess cytotoxic activity of the extract, cells were exposed to EEP over 72 h.
Cell viability was assessed by means of MTT assay. The percentage of cell growth inhibition (IC50) was analysed by
means of non-linear regression, and the absorbance values of the various investigated concentrations were subjected
to one-factor analysis of variance (ANOVA) followed by Tukey’s or Tamhane’s tests (α = 0.05).
Results: The results obtained using phytochemical screening and LC-Orbitrap-FTMS indicated the presence of
phlobaphene tannins, catechins, chalcones, aurones, flavonones, flavonols, xanthones, pentacyclic triterpenoids
and guttiferones in Brazilian red propolis. EEP and its hexane, chloroform and ethyl acetate fractions obtained
by liquid-liquid partitioning exhibited satisfactory antioxidant percentages. EEP (IC50 < 34.27 μg/mL) exhibited
high levels of cytotoxicity on all human tumour cell lines tested when compared to negative control.
Conclusions: C-Orbitrap-FTMS was useful to establish the chemical profile of the red propolis. Brazilian red propolis
has antioxidant properties and decreases substantially the percentage of cell survival of human tumour cells; thus, it
has potential to serve as an anticancer drug.
Keywords: Red propolis, Phenolic compounds, Antioxidant activity, Cytotoxic activity
* Correspondence: isabelcmporto@gmail.comAQ2AQ3
1School of Dentistry, Cesmac University Center, Rua Cônego Machado, 918,
Farol, CEP: 57051–160, Maceió, Alagoas, Brazil
Full list of author information is available at the end of the article
© 2015 de Mendonça et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
de Mendonça et al. BMC Complementary and Alternative Medicine  (2015) 15:357 
DOI 10.1186/s12906-015-0888-9
Background
The use of medicinal plants, phytotherapeutics and organo-
therapy products in the treatment of diseases is growing
worldwide and thus represents a promising market for the
development of new drugs and the treatment of complex
diseases, such as cancer [1–5].
Propolis has been known since centuries for its heal-
ing properties but recently it has captured the attention
of scientists due to its wide spectrum activities that can
be used in the complementary and alternative medicine
[6–8]. Consistently, the number of studies conducted
with this substance has exhibited a significant increase
in countries without the traditional use of natural
medicine [2, 9–12].
Propolis is a resinous substance produced from plant
buds by bees from the species Apis mellifera and serves
as a natural barrier to protect hives from invading para-
sites, bacteria and viruses [13]. Although the compos-
ition of propolis varies as a function of its botanical and
geographical origin [8, 9], it usually includes beeswaxes,
balsams, vitamins, minerals, essential oils and resin,
which are rich in secondary plant metabolites such as
phenolic compounds [8, 13, 14]. Propolis is considered
an organotherapy product because it contains organic
secretions of the bees that produce it [15]. The most
widely known pharmacologically active chemical compo-
nents in propolis are flavonoids, isoflavonoids, phenolic
acid, terpens, xanthones, propolones and guttiferones
[8, 13, 14, 16], which account for its antimicrobial
[10, 17, 18], anti-inflammatory [10, 17, 19], antioxi-
dant [19], antiviral [19], antifungal [20, 21] and anti-
cancer actions [2, 3, 11, 22], among other.
Climate variations might induce changes in the con-
centration of bioactive compounds of plants, with conse-
quent alterations in the biological activity of the various
types of propolis [23, 24]. Although, therapeutic stand-
ardisation of propolis is challenging, and the relationship
between definite types of propolis and specific biological
activities is difficult to establish [14], the presence of a
significant amount of one specific compound might lead
to the expectance that the extract has the potential to show
bioactivities linked to this potential [7, 8]. The chemical
composition of Brazilian propolis is quite different from
that of propolis from European countries as a function of
the tropical climate, plant diversity and bee species, the lat-
ter resulting from the crossing of European and African
species. Those factors play a relevant role in the physical,
chemical and biological properties of propolis [25].
Park et al. [26] have identified and classified 13 different
types of propolis in Brazil based on their physicochemical
characteristics. Red propolis is a type of Brazilian propolis
found in beehives close to mangrove swamps in the
northeast states of Alagoas, Sergipe, Bahia, Pernambuco
and Paraíba [26, 27]. The botanical origin of this newly
found red-hued propolis is a leguminous plant known
as Dalbergia ecastophyllum, which grows abundantly in
the mangrove swamps of Alagoas State. Recent studies
that sought to characterise the Brazilian red propolis
found molecules, such as elemicin, isoelemicin, methyl
isoeugenol, methyl eugenol, formononetin, biochanin A,
isoliquiritigenin, liquiritigenin, medicarpin, homopterocar-
pan, quercetin and vestitol, that allow it to be distin-
guished from other types of Brazilian propolis [19, 27, 28].
Red propolis exhibits more intense cytotoxic action and
inhibition of human leukaemia cells growth compared with
green propolis [2]. The cytotoxic activity of red propolis on
six different tumour cell lines was similar to that of antican-
cer drugs, such as 5-fluorouracil and doxorubicin [3]. Costa
e Silva [29] has verified the action of Brazilian red propolis
on murine melanoma (BB16F10), multiple human melan-
oma (RPMI 8226), promyelocytic leukemia (HL-60),
chronic myeloid leukemia (K562) and human normal lung
fibroblasts (MRC-5) cell lines. The results showed cytotoxic
effect, ie, the propolis was able to inhibit the growth of all
tumour cells by necrosis, with in average IC50 around 31.3
ug / mL in 24 h of exposure, whereas the IC50 after 24 h
exposure of normal fibroblast cells to Brazilian red propolis
was 36.4 μg / mL. Frozza et al. [30] evaluated cytotoxic
activity of Brazilian red propolis on human laryngeal epi-
dermoid cells carcinoma (Hep-2), human cervical adeno-
carcinoma cells (HeLa) and human normal epithelial
embryonic kidney cells (Hek-293). Survival analysis for
non-tumor cell line showed greater IC50 (>150 μg/mL)
compared to tumor cell lines (Hep-2 – 63.48 μg/mL and
HeLa – 81.40 μg/mL), suggesting an increased sensitivity
that may correlate with the higher proliferative index of the
tumor vs. normal cells. Studies of cytotoxicity in vitro are
part of the initial screening to identify whether the tested
substance interferes with both cell metabolism or cell
survival. At this point it is too early to attest its safety.
Although many studies prove the therapeutic and beneficial
properties of propolis, toxicity studies in vivo and in vitro
should be done to better support the safe use of propolis.
Therefore, the confirmed action of red propolis on
tumour cells [2, 3, 22], together with the implementation of
a new public healthcare model that stimulates the popula-
tion’s use and interest in natural products point to the need
to gather more information on this substance. The aim of
this study was to analyse the phytochemical profile of the
ethanolic extract of red propolis (EEP) and its fractionation,
antioxidant action of EEP and its fractionation and cyto-
toxic activity of EEP on human tumour cell lines SF-295
(glioblastoma), OVCAR-8 (ovary) and HCT-116 (colon).
Methods
Propolis sample
Red propolis raw material (300 g) was collected from
Marechal Deodoro city, State of Alagoas, Brazil. Propolis
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was collected from the Ilha do Porto apiary with geograph-
ical coordinates of South latitude: 9° 44.555′, West latitude:
35° 52.080′ and height of 18.1 m above sea level. The
access and transportation of Brazilian red propolis was pre-
viously authorised by regulatory agencies for control of
Brazilian Genetic Heritage and Biodiversity Conservation
with protocol number of acceptance 010124/2012-8.
Reagents
Roswell Park Memorial Institute 1640 (RPMI 1640) culture
medium and foetal bovine serum (FBS) were purchased
from Gibco Invitrogen (Karlsruhe, Germany). Penicillin/
streptomycin, dimethyl sulphoxide (DMSO) and salt 3-(4,5-
dimethyl-2-thiazole)-2,5-diphenyl-2-H-tetrazolium bromide
(MTT) were purchased from Sigma Chemical (St. Louis,
MO, USA). Folin-Ciocalteu reagent and 2,2-diphenyl-1-
picryhydrazyl (DPPH) were purchased from Merck KGaA
(Darmstadt, Germany). Methanol, hydrochloric acid, etha-
nol, ferric chloride, sodium hydroxide, chloroform, anhyd-
rous sodium sulphate, sulphuric acid, sodium carbonate,
gallic acid and ethyl acetate were purchased from Vetec
Química Fina Ltda. (Duque de Caxias, RJ, Brazil).
Cell culture
Tumour cell lines SF-295 (human glioblastoma), OVCAR-8
(ovary) and HCT-116 (colon) supplied by the National
Cancer Institute (USA) were grown in RPMI 1640 medium
supplemented with 10 % FBS, 2 mM glutamine, 100 μg/mL
of streptomycin and 100 U/mL of penicillin in an incubator
at 37 °C and 5 % CO2.
Preparation of experimental solutions
EEP was diluted in sterile, pure DMSO and then tested
at a concentration of 50 μg/mL (reference solution) to
establish its cytotoxic activity on SF-295, OVCAR-8 and
HCT-116 cell lines.
To establish the half-maximal inhibitory concentration
(IC50), the samples were tested in serial dilutions (0.09,
0.19, 0.39, 0.78, 1.56, 3.12, 6.25, 12.5, 25 and 50 μg/mL)
of the reference solution in culture medium and 1 %
DMSO using dilution factor 2. The wells for the negative
control were filled with the solvent used to dilute EEP
(1 % DMSO), and 0.5 μM doxorubicin, an anthracycline
antibiotic widely used in the treatment of various types
of cancer [31] was placed in the wells as a positive
control.
Assessment of EEP cytotoxicity
The MTT assay was used to establish the cytotoxicity of
EEP. SF-S95 and OVCAR-8 cells were plated at a concen-
tration of 0.1 × 106 cells/mL and the HCT-8 cells at a con-
centration of 0.7 × 105/mL; the cells were then incubated
with EEP in the above-mentioned dilutions for 72 h in an
incubator at 37 °C with 5 % CO2. The cells were
centrifuged, and the supernatant was removed. Next,
150 μL of MTT solution (methyl tetrazolium salt) was
added to each well, and the plates were incubated under
the above-mentioned conditions for three hours. Follow-
ing dissolution of the precipitate with 150 μL of pure
DMSO, the absorbance readings were performed using
the plate reader ELISA Synergy (Bio Tek Instruments,
Highland Park, Winooski, USA) at 595 nm. The test was
performed in triplicate.
Preparation of ethanolic extract of propolis (EEP)
Raw propolis (250 g) was manually grounded and placed
in a flask with 600 mL of 80 % ethanol, which was placed
on an agitator (Thornton, Model T14, USA) for 48 h.
Then, the macerate (the liquid portion) was removed
using a pipette, and the solid portion (wax) was discarded.
The macerate was mixed with 600 mL of 80 % ethanol in
a glass flask, placed on the agitator for 24 h. Then the
resulting macerate was mixed again with 600 mL of 80 %
ethanol and left for 24 h without agitation.
Next, the macerate was removed using a pipette, filtered
through filter paper and subjected to distillation under
reduced pressure in a rotary evaporator (Fisatom, São
Paulo-Brasil) in a water bath at temperature 80–90 °C,
pressure 650 mmHg and speed 80 rpm to remove the
solvent. The EEP was then placed in a glass container and
left for approximately three days for the residual solvent
to evaporate; as a result, a solid mass (162 g) with viscous
appearance was obtained.
Liquid-liquid partitioning
EEP (10 g) was fractionated by means of liquid-liquid
partitioning. For that purpose, the extract was dissolved
in methanol and water in proportion 8:2 (v/v; volume in
50 mL). It was added 15 mL of water following of vigorous
agitation and allowed to stand for a few minutes. The
methanol/water phase was used as the basis for partition-
ing, using solvents: hexane (first), chloroform (second)
and ethyl acetate (third) on this sequence according to the
gradient of polarity and both with 100 mL. In this proced-
ure a gentle agitation was used to avoid emergence of
emulsions, resulting in the hexane, chloroform and ethyl
acetate fractions, respectively. The volume of each fraction
was subjected to distillation under reduced pressure in a
rotary evaporator similar to the procedure of crude etha-
nolic extract of propolis (EEP). Solid masses were obtained
for hexane fraction, chloroform fraction and ethyl acetate
fractions after total evaporation of solvents. The EEP and
its fractions were subjected to phytochemical prospection,
assessment of the percentage of phenolic compounds and
investigation of antioxidant activity. Cytotoxicity assay was
used only for EEP.
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Phytochemical screening of red propolis extracts
Prospection of chemical components
Phytochemical screening was performed based on the
methods suggested by Matos [32], which were adapted for
the prospection of the following allelochemicals: phenols,
pyrogallic tannins, phlobaphene tannins, anthocyanin,
anthocyanidin, flavones, flavonols, xanthones, chalcones,
aurones, flavononols, leucoanthocyanidins, catechins, fla-
vanones, steroids, triterpenoids and saponins.
For phytochemical prospection, crude extract of EEP
and its fractions were exactly weighted (100 mg) solubi-
lized in absolute ethanol (40 mL) and performed the
same procedure cited for phytochemical prospection.
Then, aliquot of 35.0 mL of the samples (EPP and its
fractions in separate test tubes) were divided in seven
3.0-mL parts, which were placed in numbered (1 to 7)
and labelled test tubes, and one 10.0-mL part was placed
in a beaker. The beaker was heated in water bath on a
hot plate under agitation, until the liquid was fully evap-
orated, to assess steroids, triterpenoids and saponins.
Tests to assess phenols, pyrogallic tannins and
phlobaphene tannins
In test tube #1, three drops of solution of ferric chloride
(FeCl3) in alcohol were added to the EEP sample. Follow-
ing agitation, the tube was inspected to detect changes in
colour or abundant formation of dark-hued precipitate.
Hues ranging from blue to red indicate the presence of
phenol; bluish dark precipitate indicates the presence of
pyrogallic (hydrolysable) tannins, and green precipi-
tate indicates the presence of phlobaphene (condensed
tannins or catechins) tannins. For the purpose of
comparison, one blank test was performed with water
and ferric chloride only.
Test to assess anthocyanin and anthocyanidin, flavones,
flavonols and xanthones, chalcones and aurones and
flavononols
Test tube #2 was acidulated with hydrochloric acid (HCl)
to pH 3.0; test tube #3 was alkalinised to pH 8.5, and test
tube #4 was alkalinised to pH 11 through the addition of
sodium hydroxide (NaOH). The test tubes were inspected
for changes in colour: a change to the colour red at pH 3,
lilac at pH 8.5 and purplish-blue at pH 11 indicates the
presence of anthocyanin and anthocyanidin; the colour yel-
low at pH 11 indicates the presence of flavones, flavonols
and xanthones; red at pH 3 and purplish red at pH 11 indi-
cates the presence of chalcones and aurones; and red-
orange at pH 11 indicates the presence of flavononols.
Test to assess leucoanthocyanidins, catechins and
flavanones
Test tube #5 was acidulated through addition of HCl to
pH 2.0, and test tube #6 was alkalinised through addition
of NaOH to pH 11.0. The tubes were heated using an al-
cohol lamp for 3 min. A change in colour to red at pH 2.0
indicates the presence of leucoanthocyanidins, to brown
at pH 2.0 the presence of catechins, and to red-orange at
pH 11 the presence of flavanones.
Tests to assess flavonols, flavanones, flavononols and
xanthones
A small magnesium ribbon and 1.0 mL of concentrated
HCl were added to test tube #7. The end of reaction was
indicated by appearance of effervescence, following which,
test tubes #5 and #7 (both acidulated) were compared,
seeking to detect changes to or intensification of the red
colour, which indicates the presence of flavonols, flava-
nones, flavononols and/or xanthones, either free or the
corresponding glycosides.
Test to assess steroids and triterpenoids
The dry residue was extracted three times with 2.0 mL of
chloroform and homogenised. The solution was filtered
into a test tube, by dripping one drop at a time across a
small funnel covered by cotton with a few decigrams of
anhydrous sodium sulphate (Na2SO4). Next, 1.0 mL of
acetic anhydride was added, and the tube was gently
agitated before the addition of three drops of concentrated
sulphuric acid (H2SO4). Following agitation, the test tube
was inspected for changes in colour: evanescent blue
followed by permanent green indicates the presence of
free steroids; a hue ranging from brown to red indicates
the presence of free pentacyclic triterpenoids.
Test to assess saponins
The chloroform-insoluble residue produced in the above-
mentioned reaction was dissolved in 8.0 mL of distilled
water, and the solution was filtered through cotton into a
test tube. The test tube was then strongly agitated over
three minutes and was inspected for formation of abun-
dant persistent foam (head), which indicates presence of
saponins (saponin glycosides).
Assessment of total phenolic compounds
The EEP and its fractions were subjected to triplicate
assessment at a concentration of 2.0 mg/mL. A total of
0.5 mL of 2 N Folin-Ciocalteu reagent and 1.0 mL of
water were added per 0.5 mL of the propolis sample,
and the tubes were agitated over two minutes. Next,
0.5 mL of 10 % sodium carbonate (Na2CO3) was added.
Following incubation for two hours at room temperature
with the tubes protected from light, absorbance was
measured using a spectrophotometer (Model UV-1700,
Shimadzu, Kyoto, Japan) at 750 nm. Methanol was used
as blank [33].
Gallic acid (100 mg) was exactly weighted and trans-
ferred for volumetric flask (10 mL) and solubilised with
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methanol to obtain a stock solution (10.0 mg/mL). Gallic
acid stock solution was diluted for concentrations of
1.0 mg/mL and solubilised with methanol to obtain work
solution and aliquots of 0.150, 0.100, 0.050, 0.025, 0.010
and 0.005 mL were transferred for volumetric flask of
10 mL and solubilised with methanol to obtain concentra-
tion of 15.0, 10.0, 5.0, 2.5, 1.0 and 0.5 μg/mL and they
were used for the calibration curve. The values of the total
phenolic compounds were expressed as gallic acid equiva-
lents (mg of gallic acid (GA)/g of sample) [33].
LC-Orbitrap-FTMS red propolis EEP
Markers of red propolis quality were identified using high
performance liquid chromatography (HPLC) coupled to an
ultraviolet detector (Shimadzu). The propolis tincture was
prepared at 100 mg/mL in ethanol and diluted to a concen-
tration of 1 mg/mL and used in LC-Orbitrap-FTMS.
The LC-orbitrap-FTMS from Thermo Scientific was
used with the following conditions. The stationary phase
was a C18 column from ACE (100 × 4.6 mm; 5 μm),
and the flow rate was 0.30 mL/min. The mobile phase
consisted of (A) 0.1 % formic acid in water: 0.1 % of for-
mic acid in acetonitrile (B) (v:v) in gradient mode. The
column was eluted in gradient mode as follows: starting
with 30 % of (B), increasing to 45 % in 6 min, 60 in
10 min, 75 in 14 min, 90 in 18 min and 100 in 22 min
and held at 100 % B between 22–47 min; then, the gradi-
ent decreased to 30 of (B) in 52 min and held at 30 % B
between 52–58 min. The FTMS was set to acquire ions
in negative mode with a needle voltage of 4.0 kV and
sheath gas and auxiliary gas flows of 50 and 10 arbitrary
units. The instrument was scanned over the range of 50
to 1200 amu. A volume of 10 μL was injected into the
LC-orbitrap-FTMS. The spectra were acquired in nega-
tive ion mode with the same source settings as described
above and with collision energy of 35 V. Xcalibur 2.2
software from Thermo Fisher Scientific was used to
check the raw LC–Orbitrap-FTMS data and generate
the MS based chromatograms and masses and formula
of the major chromatographic peaks. Xcalibur features
from each chromatographic peak was selected based on
the peak area and putatively identified by searching for
the accurate mass in Dictionary of Natural Products
(version 2013), then identified by online library con-
nected to pubchem database.
Assessment of antioxidant activity by means of the DPPH
methods
Quantitative assessment of the antioxidant activity of red
propolis EEP and its fractions were performed according
to the methods described in the literature [33, 34] with a
few modifications. The solvent ethanol was used as blank.
The inhibition of free radical DPPH by the samples was
monitored by measuring the decrease in absorbance of
solutions with different concentrations.
The EEP, hexane, chloroform and ethyl acetate fractions
of EEP at an initial concentration of 1.0 mg•mL−1 were di-
luted with ethanol until achieving final concentrations of
25.0, 15.0, 10.0, 5.0 and 2.5 μg•mL−1. Then, 1.0 mL of
0.3 mM DPPH in ethanol was added to 2.5 mL of the EEP
and it fractions, and the reaction was left to develop in dark
at room temperature (26 °C) over 30 min. The absorbance
readings were then performed with a spectrophotometer
(Model UV-1700, Shimadzu, Kyoto, Japan) at 518 nm.
Statistical analyses
The mean ± standard deviation of the mean (SDM) relative
to the percentage of cell growth inhibition was used to esti-
mate the IC50 and determined by means of non-linear re-
gression using software GraphPad Prism, version 5.0. One-
factor analysis of variance (ANOVA) followed by Tukey’s
or Tamhane’s tests (homogeneous or heterogeneous vari-
ance, respectively, Shapiro-Wilk p < 0.05) were employed
for analysis of the MTT assay results using software Statis-
tical Package for Social Sciences (SPSS, version 21). The
significance level was set as p < 0.05.
Results
Cytotoxicity assay
The first tests, conducted with EEP at a concentration of
50 μg/mL, revealed intense cytotoxic activity against SF-
295 (100), OVCAR-8 (93.54) and HCT-116 (98.12 %) cells
(Table 1). The cytotoxic effect of EEP did not exhibit rele-
vant variation among the tested cell lines.
Cell viability 72 h after exposure to various EEP concen-
trations is presented in Fig. 1. From concentrations of 0.09
to 12.5 μg/mL, EEP promoted discrete cell proliferation,
which was not significantly different from the negative con-
trol. The percentage of viable cells (MTT assay) following
exposure to EEP in concentrations up to 25 μg/mL was not
significantly different from the negative control. At a con-
centration of 50 μg/mL, EEP exerted significant cytotoxic
activity against all three investigated cell lines, compared to
negative control. The viability of HCT-116 and OVCAR-8
cells exposed to EEP (50 μg/mL) did not exhibit significant





(24.28 – 48. 37)
28.76 (24.42 – 33.87)
Doxorubicin 0.12 (0.09 – 0.17) 0.24 (0.2 – 0.27) 0.26 (0.17 – 0.30)
Assessment of both Brazilian red propolis extract (EEP) and Doxorubicin
cytotoxicity (MTT assay) 72 h after incubation with three tumour cell lines. IC50
and 95 % confidence interval - CI (μg/mL) calculated based on the mean and
corresponding standard deviation of the mean and determined through
non-linear regression
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differences compared with those exposed to doxorubicin,
which is a standard anticancer drug. The SF-295 cells
exhibited a greater resistance to EEP (50 μg/mL), showing a
significant difference compared with the positive control.
All three cell-lines exhibited a similar response to the vari-
ous EEP concentrations, without significant differences
among them.
Phytochemical screening, total phenolic compounds and
antioxidant activity of red propolis
The presence or absence of the investigated allelochem-
icals in EEP and its fractions are shown in Table 2. Pro-
spection of the phytochemical components of EEP and
its fractions detected the presence of phenolic com-
pounds including flavonoids (catechins, chalcones,
aurones, flavones and flavonols), phlobaphene tannins,
xanthones and pentacyclic triterpenoids (Table 2). The
concentration of the total phenolic compounds in EEP
and its fractions is depicted in Fig. 2. The chloroform
fraction (0.178 mg GA/g) showed the highest values of
total phenolic compounds following by hexane fraction
(0.160 mg GA/g) and ethyl acetate fraction (0157 mg
GA/g) and EEP (0.1585 mg GA/g).
The percentage of antioxidant activity (%AOA) of EEP
and the hexane, chloroform and ethyl acetate fractions
were assessed by the DPPH method and is shown in
Table 3. The antioxidant activity of EEP, ethyl acetate frac-
tion, chloroform fraction and hexane fraction presented
Fig. 1 Cell viability 72 h after exposure to various EEP concentrations. Cell survival is expressed as a percentage relative to the negative control (DMSO).
EEP at a concentration of 50 μg/mL, exhibited cytotoxic activity against HCT-116 and OVCAR-8 cells, without a significant difference compared with the
positive control (0.5 μM doxorubicin). Compared with the other two cell lines, SF-295 cells exposed to EEP at a concentration of 50 μg/mL exhibited a
significantly higher survival rate compared with those exposed to doxorubicin. Each bar graph represents the mean, and the error bars represent ± SD of
three independent experiments performed in triplicate







Phenols Na N N N
Pyrogallic tannins N N N N
Phlobaphene
tannins
Pa P P P
Anthocyanin and
anthocyanidin
N N N N
Flavones, flavonols
and xanthones
P P N P
Chalcones and
aurones
P P P N
Flavononols N N N N
Leucoanthocyanidins N N N N
Catechins P P P N
Flavonones N N N N
Steroids N N N N
Triterpenoids P P P P
Saponins N N N N
Phytochemical screening detected presence of phlobaphene tannins, flavones,
flavonols, xanthones and pentacyclic triterpenoids in EEP and its chloroform,
hexane and ethyl acetate fractions
aP positive, N negative
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IC50 in concentrations 1.8, 2.4, 2.8, 2.8 times, respectively,
lower compared to the positive control (trolox) indicating
a superior antioxidant activity in relation to trolox drug.
LC - Orbitrap-FTMS of the red propolis EEP
LC-Orbitrap-FTMS analysis revealed a group of substances
that eluted at 3 to 25 min, which corresponds to the group
of flavonoids flavonoids such as: phenolic acids, flavan-3-ol
(catechins), flavonols, chalcones, isoflavones, isoflavans,
pterocarpans and biflavonoids present in Brazilian red
propolis, and a group of substances that eluted at 25 to
48 min, which exhibited the characteristic molecular weight
of terpens, and guttiferones. The LC-Orbitrap-FTMS chro-
matogram from EEP is shown in Fig. 3. The main phenolic
compounds found in EEP were characterized by LC-FTMS
analyses (Table 4). Phytochemical screening (chemical reac-
tion assay) also detected chalcones, flavan-3-ol (catechins),
flavonols, but failed to detect other compounds present in
EEP such as guttiferones. LC-Orbitrap -FTMS analysis
revealed the presence of phlobaphene tannins, guttiferones
and some terpenic substances described in Table 3 within
the range of 3 to 50 min.
Discussion
The propolis produced in tropical areas contains a wide
variety of phenolic compounds, such as p-coumaric acid,
flavan-3-ol, flavonols, chalcones, isoflavonoids, pterocar-
pans, methoxylated isoflavones, triterpenoids and guttifer-
ones [35]. The flavonoids are the main substances that
account for the antioxidant [36], anticancer [29, 34, 37]
and anti-inflammatory [37] properties of propolis, as well
as its protective effects on the kidney, liver and cardiovas-
cular system [36]. Phenolic compounds including formo-
nonetin, biochanin A, isoliquiritigenin, pinocembrin and
quercetin, the latter in reduced amounts, have been de-
tected in Brazilian red propolis [17]; these compounds ex-
hibit cytotoxic activity against HepG2 (human hepatic
carcinoma cells), Hep-2 (human laryngeal epidermoid car-
cinoma cells) and HeLa (human cervical adenocarcinoma)
cancer cell lines [30]. In the present study, the tests to de-
tect phenolic compounds in EEP showed the presence of
flavones and flavonols in its chloroform fraction, and the
high levels of cytotoxicity exhibited by EEP at a concentra-
tion of 50 μg/mL might be attributed to these
compounds.
In concentrations up to 12.5 μg/mL, the percentage of vi-
able cells was slightly higher than the negative control. This
result might be due to the cytoprotective effects associated
with the antioxidant properties of propolis [38]. The cyto-
toxic activity exhibited a gradual concentration-dependent
increase starting at a concentration of 25 μg/mL. The num-
ber of surviving cells (HCT-116 and OVCAR-8) in the
Fig. 2 Concentration of phenolic compounds in mg of gallic acid equivalents/g of extract detected in EEP and fractions diluted in hexane, chloroform
and ethyl acetate. The highest values corresponded to the chloroform fraction
Table 3 Antioxidant activity (%AOA) of EEP and its fractions
Concentration (μg/mL) / (%AOA)
25.0 15.0 10.0 5.0 2.5 1.0 IC50 (μg/ml)
EEP 86.57 73.43 64.18 38.51 25.97 11.34 8.01
hexane fraction 90.42 87.04 76.62 49.00 44.22 18.87 5.15
chloroform fraction 86.86 84.18 69.55 47.16 41.19 16.79 5.20
ethyl acetate fraction 88.73 76.90 59.44 34.93 24.79 11.27 6.01
Trolox 68.30 50.02 28.00 12.98 6.07 3.02 14.68
Free radical DPPH sequestering activity (%) of the ethanolic extract of Brazilian red propolis and its hexane, chloroform and ethyl acetate fractions
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group exposed to EEP at a concentration of 50 μg/mL was
similar to those treated with doxorubicin, a drug routinely
used for anticancer treatment. These findings are in agree-
ment with the results of the study conducted by Li et al. [3]
using propolis from the same area as in the present
study on six different tumour cell lines. In that study,
the activity of propolis was similar to that of the investi-
gated anticancer drugs (5-fluorouracil and doxorubicin).
An increasing number of epidemiological studies have
suggested that flavonoid intake might be associated with a
reduced risk of cancer [37]. This observation has been
confirmed in in vitro [39], in vivo [40] and in clinical stud-
ies conducted on humans [41].
According to the previous study, propolis interferes with
cell replication by inducing apoptosis in cells exhibiting
disorganised patterns of growth [42] and also acts in the
repair of the damage caused by oxygen free radicals, which
might be attributable to the antioxidant activity of its
phenolic compounds [30].
Others studies indicated that red propolis induces
apoptosis on human tumour cells [2, 12] that might be
the mechanism behind the high index of cell inhibition
induced by EEP at a concentration of 50 μg/mL showed
in this study. Similar effect was also demonstrated by
Begnini et al. [22] that found the ethanolic extract of red
propolis at concentrations of 50 and 100 μg/mL induced
high levels of apoptosis in bladder carcinoma cells.
The cell death type was not assessed in the present study;
however, according to Kamya et al. [43], who also tested
Brazilian red propolis on tumour cells, EEP signifi-
cantly reduced the viability of MCF-7 human breast
cancer cells through apoptosis triggered by induction
of mitochondrial dysfunction, caspase-3 activity and
DNA fragmentation.
There is consensus among researchers that reactive oxy-
gen species (reactive molecules and free radicals derived
from molecular oxygen) plays a relevant role in mutagen-
esis and carcinogenesis, based on its ability to damage
DNA. Antioxidants play a crucial role in the interception
of free radicals and the repair of free radical-induced dam-
age. In addition, that process is related to the removal of
damage from the DNA molecule and the reconstitution of
damaged cell membranes [44, 45].
In this study the antioxidant activity of EEP and its
fractions was determined by in-vitro antioxidant assay
using 2,2-diphenyl-2-picryl-hydrazyl free radical (DPPH)
scavenging [46]. The antioxidant action of propolis is
attributed to its component flavonoids, among which we
might mention quercetin, daidzein, apigenin and genistein
[42]. Quercetin and daidzein have been detected by Franchi
Jr. et al. [2] in Brazilian red propolis from Alagoas State.
Others studies also detected antioxidant activity of the
flavonoids isoliquiritigenin [47] and pinobanksin [48] in red
propolis.
In the present study, quantitative in vitro analysis
found that the antioxidant activity of EEP and its frac-
tions (hexane, chloroform and ethyl acetate) were satis-
factory, particularly in the case of the chloroform and
hexane fractions, being in decreasing order, chloroform
fraction > hexane fraction > EEP ≅ ethyl acetate fraction.
The greater antioxidant activity of the chloroform and
hexane fractions correlates with the higher concentration
of phenolic compounds in those fractions compared with
the other. These results are in agreement with those
reported by Cabral et al. [46] upon assessing the antioxi-
dant activity of Brazilian red propolis.
Chloroform fraction and hexane fraction were enriched
with phenolic compounds of red propolis during liquid-
Fig. 3 Chromatogram of EEP obtained by means of LC-Orbitrap-FTMS
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liquid extraction and was dependent of the partition coef-
ficient (K) of the phenolic compounds in the solvents
chosen for this procedure of extraction. The hexane frac-
tion presented the second highest total phenolic compound
values. This can be justified due to partition coefficient (K)
of these compounds resulting in the migration of phenolic
compounds during partitioning process of liquid-liquid
extraction [49]. Plus the lack of selectively of the hexane
Table 4 Identification and confirmation of biomarkers of Brazilian red propolis in EEP using LC-Orbitrap-FTMS
Peak m/z RT (min) Formulae Compound
1 179.0556 2.95 C9H8O4 Caffeic acid
2 193.0502 2.98 C10H10O4 Ferulic acid
3 179.0556 3.00 C9H8O4 Umbelic acid
4 163.0243 3.04 C9H8O3 p-Coumaric acid
5 475.1232 3.10 C23H24O11 7-O-beta-glucopyranosyl-4′-hydroxy-5-methoxyisoflavone
6 461.1073 4.50 C22H22O11 6-Methoxyluteolin 7-rhamnoside
7 269.0811 7.05 C15H10O5 Genistein
8 285.0395 7.35 C15H10O5 Kaempferol
9 289.0711 8.04 C15H14O6 Cathechin
10 287.0553 8.28 C15H12O6 Dalbergioidin
11 289.0711 8.83 C15H14O6 Epicatechin
12 253.0499 8.95 C15H10O4 Daidzein
13 255.0655 9.7 C15H12O4 Liquiritigenin
14 283.0603 10.5 C16H12O5 2′-Hydroxyformononetin
15 331.0810 11.3 C17H16O7 Evernic acid
16-17 271.0605 11.9 C15H12O5 Naringenin
Pinobanksin
18 283.0604 12.4 C16H12O5 Calycosin
19 255.0656 13.4 C15H12O4 Isoliquiritigenin
20-21 267.0656 13.8 C16H12O4 Formononetin
Isoformononetin
22 269.0812 14.2 C16H14O4 4,4′-dihydroxy-2-methoxychalcone
23 269.0812 14.2 C16H14O4 (7S)-dalbergiphenol
24 271.0969 14.7 C16H16O4 Vestitol
25 269.0813 15.1 C16H14O4 Pinostrobin
26 269.0813 15.1 C16H14O4 Medicarpin
27 255.0657 16.2 C15H12O4 2′,6′-dihydroxy-4′-methoxydihydrochalcone
28 255.0657 16.2 C15H12O4 Thevetiaflavone
29 539.1699 17.0 C32H28O8 3′,4′-di-O-benzyl-7-O-(2-hydroxyethyl)-3-O-methylquercetin
30-31 285.1131 18.2 C17H18O4 (3S)-7-O-methylvestitol
7,3′-Dihydroxy-4′-methoxy-8-methylflavane
32-34 425.1603 21.4 C30H50O Cycloartenol
α-amyrin
β-amyrin
35-37 601.3533 32.9 C38H50O6 Guttiferone E
Guttiferone F
Xantochymol
38-39 669.4156 39.2 C43H58O6 Guttiferone C
Guttiferone D
40 401.3058 48.4 C26H42O3 19-nor-10-keto-25-hydroxyvitamin D3
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and chloroform solvents for phenolic compounds present
in red propolis, which present an semi-polar nature such as
methoxylated isoflavonoids (formononetin) and prenylated
phenolic compound (guttiferone) (Table 4) and xanthones
(Table 2) besides of phlobaphene tannins (Table 2) in all
samples detected in phytochemical prospection.
Generally, phytochemicals prospection assays are quali-
tative, quick and low-cost methods and assure presence or
absence of different classes of secondary metabolites. But
an aspect to be considered is that the crude extract (EEP)
can present various substances of polar, semi-polar, and
non-polar nature with much interference and become the
sample very complex to detect presence of compounds.
Other aspect to be considered is the lack of selectivity of
the solvents and can be a limiting factor on the assay. This
lack of selectivity of the solvents also can be explained by
the theory of partition coefficient (K) of the analytes. Ana-
lytes can be partitioned by solvents and depending on: 1)
concentration of analytes; 2) solubility of analytes in solv-
ent of extraction; 3) volume of the solvent of extraction; 4)
the nature of analytes (acid or base); 5) pH of the aqueous
phase.
In our experiment, the extraction of phenolic com-
pounds by hexane solvent was conducted by 1) Large
amount of the crude mass (crude extract) resulting in
low concentration of crude mass after first liquid-liquid
partitioning (theorical concentration of crude mass was
less than 100 mg/mL); 2) and volume of 100 mL (large
amount of solvent of extraction, hexane solvent); 3) no
control of pH in aqueous medium and it favored the
partitioning process of liquid-liquid extraction in non-
polar solvent (hexane) despite phenolic compound have
a limited solubility by hexane solvent.
The modern technique of phytochemical prospection
using LC-Orbitrap-FTMS demonstrated to be more spe-
cific in the identification of the exact biomarkers of red
propolis independently of the class of secondary metabo-
lites (biomarkares). It was possible to detect the presence
of polyisoprenylated guttiferones (35–39), terpens (32–34),
pterocarpan (26), isoflavans (24), isoflavones (20–21), chal-
cone (19), flavonone (16), dihydroflavonol (17), flavonols
(8), phenolic acids (9), flavans (4) (See Table 4) and which
are considered as bioactive markers in this type of Brazilian
propolis. Tannins and xanthones are phenolic compounds
with remarkable antioxidant activity [50]. The presence of
tannins and xanthones along with the flavonoids might
also account for the antioxidant and anticancer activity
exhibited by EEP in this study [30, 38, 42, 46].
LC-Orbitrap-FTMS can be considered the best choice
to detect any substance because MS is a universal detector
in large range of masses. LC-Orbitrap-FTMS is more sen-
sitive and robust for detecting different compounds in
different range of masses because Orbitrap is an import-
ant component in this equipment because can concentrate
the ions during the detection. For LC-Orbitrap-FTMS a
concentration of 1 mg/mL (1000 μg/mL) of crude extract
was prepared and only 10uL (10 μg) was injected in the
chromatographic column. This amount is enough to
detect in the mass spectrometer using the orbitrap mode
due to the sensibility of the technique to detect a hundred
compounds in simple analysis [51]. Thus it is the best
choice technique to evaluate the chemical profile analysis
and modern fingerprint of complex samples like phyto-
chemicals and apiceuticals.
Conclusions
It was possible to confirm the presence of phlobaphene
tannins, catechins, flavones, flavonols, chalcones, isofla-
vans, pterocarpans, isoflavonoids, biflavonoids, pentacyclic
triterpenoids, xanthones and guttiferones in EEP using the
classical chemical prospection and a modern analytical
technique such as LC-Orbitrap-FTMS. LC-Orbitrap-
FTMS was useful to establish the chemical profile of the
red propolis. Brazilian red propolis exhibited antioxidant
activity and in higher concentration it showed high cyto-
toxic potential on the human tumour cell lines SF-295,
HCT-116 and OVCAR-8. Therefore, it might be useful for
the development of new medicines and phytomedicines
for the treatment of cancer.
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